Cws Financial Advisors, LLC Eli Lilly & CO Transaction History

Cws Financial Advisors, LLC

$277 Million
Q3 2024

A detailed history of Cws Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cws Financial Advisors, LLC holds 1,200 shares of LLY stock, worth $875,676. This represents 0.38% of its overall portfolio holdings.

Number of Shares

1,200

Previous 1,118 7.33%

Holding current value

$875,676

Previous $1.01 Million 5.04%

% of portfolio

0.38%

Previous 0.4%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $63,315 - $78,721	82 Added 7.33%	1,200 $1.06 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $32,619 - $40,906	-45 Reduced 3.87%	1,118 $1.01 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $422,238 - $564,895	-713 Reduced 38.01%	1,163 $904,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $43,470 - $59,929	-100 Reduced 5.06%	1,876 $1.01 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 4.82%	1,976 $926,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $120,524 - $141,550	388 Added 22.99%	2,076 $712,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $1,607 - $1,873	5 Added 0.3%	1,688 $617,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $19,864 - $22,637	-67 Reduced 3.83%	1,683 $544,000
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $10,591 - $12,436	38 Added 2.22%	1,750 $567,000
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $1,877 - $2,333	8 Added 0.47%	1,712 $490,000
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $3,822 - $4,743	17 Added 1.01%	1,704 $471,000
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $180 - $233	-1 Reduced 0.06%	1,687 $387,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $62,934 - $81,471	383 Added 29.35%	1,688 $315,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $28,701 - $37,978	-220 Reduced 14.43%	1,305 $220,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $76,034 - $87,947	-520 Reduced 25.43%	1,525 $226,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $57,023 - $68,627	418 Added 25.69%	2,045 $336,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $173,958 - $215,463	1,627 New	1,627 $214,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cws Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cws Financial Advisors, LLC with notifications on news.

Account

Cws Financial Advisors, LLC Eli Lilly & CO Transaction History